expr:href='data:blog.homepageUrl + "favicon.ico"' rel='icon' type='image/x-icon'/> India's First COVID-19 Vaccine "COVAXIN" Approved For Human Trials!

India's First COVID-19 Vaccine "COVAXIN" Approved For Human Trials!

COVAXIN


"COVAXIN" Approved For Human Trials!


The outbreak of the COVID-19 has brought the world to a halt. A worldwide lockdown has been imposed and people are being quarantined by the dozen. As the infections rise and death rate surges, officials are struggling hard to find a cure.

Many major players in the pharmaceutical sector are in the race for making the first COVID-19 vaccine. However, it seems that India might be leading this race. Developed by Bharat Biotech, India's First COVID-19 Vaccine "COVAXIN" Approved For Human Trials! The potential COVID-19 vaccnine is developed by Bharat Biotech in collaboration with the 

Indian Council Of Medical Research (ICMR) and the National Institute Of Virology (NIV).

Bharat Biotech is a pharmaceutical company based out of Hyderabad, Andhra Pradesh. COVAXIN might be India's First COVID-19 Vaccine Approved For Human Trials. The 
Drug Controller General Of India (DCGI) has given their approval to Bharat Biotech to conduct Phase 1 and Phase 2 human clinical trials of the potential COVID-19 vaccine COVAXIN.
NEXT ARTICLE Next Post
PREVIOUS ARTICLE Previous Post
NEXT ARTICLE Next Post
PREVIOUS ARTICLE Previous Post
 

Delivered by FeedBurner